1. The Broad Institute, Inc. (11 from 443 patents)

2. Novartis Ag (9 from 3,923 patents)

3. Bayer Aktiengesellschaft (8 from 12,157 patents)

4. Bayer Pharma Aktiengesellschaft (8 from 378 patents)

5. Bristol-myers Squibb Compnay (7 from 3,681 patents)

6. Anji Pharmaceuticals Inc. (3 from 6 patents)

7. Astrazeneca Ab (2 from 1,500 patents)

8. Tabomedex Biosciences, LLC (2 from 2 patents)

9. Other (1 from 832,680 patents)

10. The General Hospital Corporation (1 from 2,882 patents)

11. The Brigham and Women's Hospital, Inc. (1 from 1,370 patents)

12. Flash Therapeutics (1 from 4 patents)

13. Serleva, Inc. (1 from 1 patent)

1. 12343334 - Compositions and methods for treating severe constipation

2. 12152041 - Macrocyclic fluorine substituted indole derivatives

3. 11963960 - Compounds for treating or inhibiting recurrence of acute myeloid leukemia

4. 11891404 - Substituted macrocyclic indole derivatives

5. 11819495 - Compositions and methods for treating severe constipation

6. 11679146 - Compositions and methods for treating pancreatitis

7. 11603523 - PCSK9 inhibitors and methods of use thereof

8. 11492358 - Macrocyclic indole derivatives

9. 11478451 - Macrocyclic chlorine substituted indole derivatives

10. 11447504 - Macrocyclic chlorine substituted indole derivatives

11. 11440923 - Substituted macrocyclic indole derivatives

12. 11401278 - Macrocyclic indole derivatives

13. 11286263 - Macrocyclic fluorine substituted indole derivatives

14. 11248001 - PCSK9 inhibitors and methods of use thereof

15. 11224590 - Compositions and methods for treating severe constipation